Food News and Research

RSS

American Society of Hematology offers recommendations to propel collaborative research in regenerative medicine

The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."

13 Aug 2010

FDA grants new 510(k) clearance for Fenwal's Amicus blood cell separator

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.

13 Aug 2010

Antares Pharma second-quarter total revenue increases 78% to $3.1 million

Antares Pharma, Inc. today reported financial and operating results for the second quarter ended June 30, 2010.

13 Aug 2010

Superbug purportedly from Asia on the rise in UK & Australia

British scientists have claimed that a new gene called New Delhi metallo-beta-lactamase, or NDM-1 has emerged that makes the bacteria resistant to almost all antibiotics. India has rejected the claim that it is the source of this superbug. Cases have been detected in the UK and Australia and are on the rise in the UK.

12 Aug 2010

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

LifeCycle Pharma A/S today announced receipt of agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment of its pivotal Phase 3 study, Study 3002, for LCP-Tacro in patients, who have just received a kidney transplant.

12 Aug 2010

Fast food outlets can provide statin drugs to help customers neutralise heart disease: Researchers

Fast food outlets could provide statin drugs free of charge so that customers can neutralise the heart disease dangers of fatty food, researchers at Imperial College London suggest in a new study published this week.

12 Aug 2010

Survey finds high level of noncompliance with PPE protocols among safety professionals

Nearly all of the safety professionals in a survey released today said that workers in their organizations had at some point failed to wear the necessary safety equipment while on the job. An exceedingly high 98 percent of respondents who attended the recent American Society of Safety Engineers (ASSE) show in Baltimore answered "yes" when asked if they had observed workers not wearing safety equipment when they should have been, according to the survey, which was conducted by Kimberly-Clark Professional.

12 Aug 2010

Aeterna Zentaris second-quarter revenues decrease to $5.6 million

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results for the second quarter ended June 30, 2010.

12 Aug 2010

Perrigo fourth-quarter fiscal 2010 net sales up 22%

Perrigo Company today announced results for its fourth quarter and full year ended June 26, 2010.

12 Aug 2010

Pharmasset receives fast track designation from FDA for PSI-7977

Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.

12 Aug 2010

FDA grants BioMimetic Therapeutics orphan drug designation for rhPDGF-BB in treatment of OCD

BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.

12 Aug 2010

FDA advisory committee votes in favor of Ezogabine

The U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of Ezogabine (known as Retigabine outside of the U.S.) as adjunctive treatment for adults with partial-onset seizures.

12 Aug 2010

NYBC calls for blood donations

New York Blood Center, serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to remember your neighbors during this slow, late summer period for blood donations – and schedule a donation appointment or consider sponsoring a blood drive, because patients' needs do not take a summer break.

12 Aug 2010

BioPharm Asia subsidiary acquires all outstanding equity interests of TBWF

BioPharm Asia, Inc. announced today that on August 7, 2010, its wholly-owned subsidiary, Tonghua Huachen Herbal Planting Company Limited, acquired all of the outstanding equity interests in Tonghua Tianbao Wood Frog Cultivation Limited Company for a purchase price of $4,000,000.

12 Aug 2010

U.S. announces additional $20M in flood aid for Pakistan

The U.S. will give an additional $20 million to aid Pakistan, bringing the total amount of flood assistance to $55 million, Mark Ward, acting director of the U.S. Office of Foreign Disaster Assistance, told reporters at a press briefing Tuesday, Agence France-Presse reports.

12 Aug 2010

Boston Scientific announces resolution of corporate warning letter

Boston Scientific Corporation today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in the Company's corporate warning letter have been resolved.

12 Aug 2010

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

12 Aug 2010

Scientific research on effects of oil-eating bacteria in Gulf of Mexico waters

The environmental impact of millions of gallons of oil still in the Gulf of Mexico from the Deepwater Horizon incident may depend on microscopic helpers: Bacteria that consume oil and other hydrocarbons and could break down the spilled crude, making it disappear. That's the topic of an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

12 Aug 2010

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures.

12 Aug 2010